Recombinant FVIIa in the treatment of bleeding in acquired hemophilia.
Guerin
Viviane
V
Chossat
Isabelle
I
Dutronc
Herve
H
Dubreuil
Marc
M
Valentin
François
F
D000368:Aged; D000369:Aged, 80 and over; D001323:Autoantibodies / Q000097:blood; D004359:Drug Therapy, Combination; D005167:Factor VII / Q000627:therapeutic use*; D005169:Factor VIII / Q000276:immunology; D015942:Factor VIIa; D005260:Female; D006467:Hemophilia A / Q000188:drug therapy / Q000209:etiology / Q000276:immunology*; D006470:Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D011994:Recombinant Proteins / Q000627:therapeutic use*; D016896:Treatment Outcome
D001323:Autoantibodies; D007166:Immunosuppressive Agents; D011994:Recombinant Proteins; D005167:Factor VII; D005169:Factor VIII; C103587:recombinant FVIIa; D015942:Factor VIIa